Andreas Lackner Selected Research

Andreas Lackner Research Topics

Disease

13	Neoplasms (Cancer) 01/2015 - 03/2002
4	Leukemia 01/2015 - 06/2007
4	Hepatocellular Carcinoma (Hepatoma) 06/2012 - 11/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 10/2009
2	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 09/2008
2	Herpes Zoster Oticus (Geniculate Neuralgia) 09/2010 - 09/2008
2	Polyps 08/2007 - 11/2006
2	Rhinosinusitis 08/2007 - 11/2006
1	Nevus (Nevi) 10/2017
1	Melanoma (Melanoma, Malignant) 10/2017
1	Conductive Hearing Loss 01/2016
1	Sensorineural Hearing Loss 06/2013
1	Sudden Hearing Loss (Sudden Deafness) 06/2013
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 07/2012
1	Carcinoid Tumor (Carcinoid) 01/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Vertigo (Positional Vertigo) 12/2011
1	Paralysis (Palsy) 09/2010
1	Herpes Labialis (Fever Blister) 09/2010
1	Hyperthermia 06/2009
1	Lymphoma (Lymphomas) 03/2009
1	Infections 09/2008
1	Nasal Obstruction 08/2007
1	Sinusitis 08/2007
1	Nasal Polyps (Nasal Polyp) 11/2006
1	Inflammation (Inflammations) 11/2006
1	Hypersensitivity (Allergy) 07/2003

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2006
6	Proteins (Proteins, Gene)FDA Link 10/2017 - 08/2007
5	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2013 - 06/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015 - 11/2007
3	ResveratrolIBA 10/2013 - 11/2007
2	Messenger RNA (mRNA)IBA 10/2017 - 08/2007
2	PolyphenolsIBA 01/2015 - 10/2009
2	EnzymesIBA 10/2013 - 10/2009
2	ErbB Receptors (EGF Receptor)IBA 06/2012 - 01/2012
2	Green Fluorescent ProteinsIBA 01/2012 - 06/2010
2	AvemarIBA 03/2009 - 06/2007
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Uric Acid (Urate)IBA 01/2016
1	Rosmarinic AcidIBA 01/2015
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2015
1	triphosphoric acid (triphosphate)IBA 01/2015
1	Ellagic AcidIBA 01/2015
1	Free RadicalsIBA 01/2015
1	digalloylresveratrolIBA 10/2013
1	Indicators and Reagents (Reagents)IBA 06/2013
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2012
1	major vault proteinIBA 06/2012
1	Everolimus FDA Link 01/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	PuromycinIBA 01/2012
1	TOR Serine-Threonine KinasesIBA 01/2012
1	N-hydroxy-N'-aminoguanidineIBA 01/2011
1	Antiviral Agents (Antivirals)IBA 09/2010
1	ProteomeIBA 06/2010
1	Cyclin D1IBA 10/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2009
1	Methylene Chloride (Dichloromethane)IBA 04/2009
1	RNA (Ribonucleic Acid)IBA 09/2008
1	N- hydroxy- N'- (3,4,5- trimethoxyphenyl)- 3,4,5- trimethoxy- benzamidineIBA 11/2007
1	Interleukin-16 (Interleukin 16)IBA 08/2007
1	Biological ProductsIBA 11/2006
1	Interleukin-5 (Interleukin 5)IBA 11/2006
1	activin AIBA 11/2006
1	FollistatinIBA 11/2006
1	Eosinophil Cationic ProteinIBA 11/2006
1	reslizumabIBA 11/2006

Therapy/Procedure

4	Therapeutics 10/2017 - 06/2009
3	Drug Therapy (Chemotherapy) 01/2011 - 06/2007
1	Conservative Treatment 12/2011
1	Nasal Surgical Procedures 08/2007
1	Intravenous Administration 11/2006
1	Intravenous Infusions 11/2006
1	Adenoidectomy 07/2003
1	Reoperation 03/2002